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     ABSTRACT 
When instantaneous step-wise transitions within the moderate intensity domain are initiated from 
elevated metabolic rates, the rate of pulmonary oxygen uptake ( 2pOV& ) adjustment is slowed, and 
the 2pOV& gain (∆ 2pOV& /∆WR) is greater. This study sought to determine the relationship 
between 2pOV& kinetics and energy status during step transitions from low and elevated metabolic 
rates within the moderate intensity domain. Ten young men completed six double-step constant 
load cycling bouts, consisting of step-wise transitions from 20 W to 45% θL and 45% θL [lower 
step (LS)] to 90% θL [upper step (US)], one double-step bout included needle  biopsies at 
baseline, steady-state values and during transitions. Gas exchange was analyzed breath-by-breath 
and muscle de-oxygenation status ([HHb]) was measured with near infrared spectroscopy. The 
2pOV& gain in the US (10.37 ± 1.49) was greater (p<0.05) than the LS (8.51 ± 1.41). The rate of 
adjustment of 2pOV&  (τ VO2p) in the US (34 ± 12 s) was slower (p<0.05) compared to the lower 
step (20 ± 8 s). τ[HHb] in the US (16 ± 5 s) was greater (p<0.05) than the LS (11 ± 5 s). 
[HHb]amp in the US (3.5 ± 2.6 a.u) was decreased (p<0.05) as compared to the LS (4.3 ± 3.5). 
[PCr] degradation, [ADPfree] and [Pi] was increased (p<0.05) during the LS exercise transition 
(LS15) and remained elevated relative to baseline through the protocol. The calculated ∆GATP 
values
 
at the LS360 and the US360 were both significantly (p<0.05) lower than baseline but not 
different from each other.  
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PREFACE 
The origins of the study of pulmonary O2 uptake ( 2OV& ) kinetics and metabolism are grounded in 
nearly hallowed antiquity. To trace the path, one must look back through the annals of both 
history and science to find the Greek term Μεταβολισµός; metabolismos, which means to 
‘overthrow’, to ‘change’ or ‘alter’. Science itself is rife with ‘overthrow’. Where once the mighty 
Greeks trusted Empedocles, citizen of modern day Sicily, when he quantified all matter was built 
of ‘four elements’, the enlightened scientific body of an 18th century Europe trusted in the lauded 
chemist Antoine Lavoisier when he realized the transition from the inhalation of air to the 
exhalation of CO2.  The foundation 2OV&  and respiratory metabolism on which this thesis is 
primarily (but not solely) focused upon, began its modern life with the pioneering work of Dr. 
Archibald Vivian Hill. Hill’s work, derived heavily from mathematics, lead him to study and 
help characterize Michaelis-Menten kinetics and also reveal the exponential-like nature of 2OV&  
at the onset of exercise. Due to this pioneering work in both metabolic and respiratory 
physiology, A.V. Hill is regarded as one of the founding fathers of the field of biophysics. 
Building on the work of Hill, and after, of Krogh and Lindhard, the work of Dr. Brian Whipp 
further elucidated the effectiveness of the human physiological system to respond to a new stress 
with a rapid kinetic response. Furthermore, Dr. Whipp was responsible for continuing the 
proliferation of knowledge, concerning the accuracy and validity of making inferences of the 
physiological state from the exercise on-transient. It is his (and others) early and pivotal work 
that cemented the field of 2OV&  kinetics as a standard measurement in exercise physiology. The 
study of 2OV&  is important simply because it governs the principal method of energy generation 
in the human body. It falls to those delving into the field of 2OV&  kinetics today to push forward, 
to continue to change, to add and to alter.  
‘The great book, always open and which one must make every effort to read, is the book of 
nature’ – Antoni Gaudi 
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CHAPTER 1  
1 REVIEW OF THE LITERATURE 
1.1 INTRODUCTION 
Coincident with an increase from rest or light exercise there is an instantaneous increase 
in the demand for adenosine triphosphate (ATP) within the working muscle (Rossiter et al. 
(1999). This instantaneous increase in demand for ATP must be met with a rapid, equivalent 
increase in ATP production. However, since indicators of oxidative phosphorylation such as 
muscle oxygen (O2) uptake ( 2mOV& ) and pulmonary oxygen uptake ( 2pOV& ), have been observed 
to be relatively slow (Grassi et al., 1996), the initial deficit in energy production must be 
contributed to up-regulated substrate-level phosphorylation (degradation of intramuscular 
phosphocreatine (PCr), increase in glycogenolysis/glycolysis and subsequent lactate production). 
However, if the exercise work rate (WR) is to be maintained, the sustained ATP demand must be 
met through a major contribution of oxidative phosphorylation. Given that the exercise transition 
intensity remains beneath the lactate threshold ( Lθˆ ) within the moderate-intensity domain 
(MOD), 2pOV& will be activated in an exponential fashion, creating a delay (dependent on the 
speed of activation) between the demand for ATP and the matched production of ATP; when the 
production of ATP matches the demand for ATP, this will create a steady-state  (Whipp, 1971). 
The reaching of this new steady-state generally occurs between 120 to 240 seconds in MOD 
exercise, however, if the exercise intensity falls above demarcations of metabolism (i.e., Lθˆ  or 
critical power) which define heavy- or severe-intensity domains of exercise, the new SS will be 
delayed or not attained at all.  The mechanism responsible for determining the rate at which 
oxidative phosphorylation activates has yet to be resolutely elucidated; despite much attention, 
the literature would suggest that there is not one exact mechanism, but instead a combination of 
O2 delivery factors, a “sluggish” activation of rate limiting enzymes and provision of oxidative 
substrate (other than O2) (i.e., reducing equivalents (NADH; FADH2, ADP, Pi) to the 
mitochondrial TCA cycle and ETC), and cellular energetic status. 
The notion that 2pOV& directly measures oxidative phosphorylation within the exercising 
muscle must be approached with considerable caution. There have been a number of modalities 
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to assess the approximation of human 2mOV& (Grassi et al., 1996; Koga et al., 2005; Krustrup et 
al., 2009). The most common of these is the measure of 2pOV& , measured at the level of the 
mouth. In the literature, 2pOV&  has been observed to be within approximately 10% of 2mOV& both 
in silico (Barstow et al., 1990) and in vivo via measuring conduit artery blood flow and arterio-
venous O2 content (i.e., a-vO2 difference) (Grassi et al., 1996; Bangsbo, 2000). Furthermore, 
employment of 31P-magnetic resonance spectroscopy (31P-MRS) has experimentally detected a 
tight matching between [PCr] degradation kinetics and the adjustment of 2pOV& and a similarly 
tight coupling between [PCr] breakdown and VO2m (Rossiter et al., 1999). Therefore, 2pOV&
kinetics remains the gold standard, non-invasive proxy for O2 consumption at the level of the 
muscle (Rossiter et al., 1999).  
The application of the MOD (i.e., exercise performed below the estimated Lθˆ ) is of 
important to the current thesis. The Lθˆ
 
is the metabolic rate at which the levels of blood lactate 
begin to increase significantly above baseline values – potentially indicating an alteration in the 
cellular processes required to drive 2pOV& (Connett et al., 1990). Pulmonary gas exchange 
responses to incremental exercise are utilized to determine at what 2pOV&  the Lθˆ occurs, which 
can then be used to determine an appropriate work rate and intensity which lies either below 
(MOD) or above (heavy; very heavy) this demarcation. During exercise that is performed within 
the MOD intensity domain, 2pOV&  exhibits an exponential-like rise towards a higher, but well-
defined steady-state. Immediately at the start of the exercise transition there is an initial rise in 
2pOV&  (Phase I, “cardio-dynamic phase”) which reflects the transit delay between the active 
muscle and the pulmonary circulation and consists of an increase in pulmonary blood flow 
(related to cardiac output) and increased venous return from the muscle due to the muscle pump 
that is activated by muscular contractions at the onset of exercise. The increase in 2pOV&  during 
‘Phase I’ does not represent any alteration in metabolism but only the rise in pulmonary blood 
flow.  After an ~20 s delay there is a more rapid increase in 2pOV&  (Phase II; fundamental or 
primary phase) which corresponds to the increase in 2mOV&  (i.e., at the level of the muscle) and is 
associated with the appearance at the lung, of deoxygenated blood from the active muscle along 
with a continuing increase in pulmonary blood flow that is related to cardiac output. Within the 
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MOD exercise domain, 2pOV&  continues to increase exponentially until it reaches a new steady 
state (Phase III). At exercise intensities above θL (i.e., heavy- or severe-intensity), a complex 
‘Phase III’ manifests itself as a delayed-onset, “extra”  2pOV&  (i.e., a 2pOV&  ‘slow’ component) 
which either delays the attainment of an steady-state (heavy-intensity) or results in a continued 
rise in the 2pOV&  response with no evidence of a steady state (very heavy-intensity). The data 
herein this thesis, however, are related only to the MOD-intensity domain.  
The adjustment of 2pOV&  following a step-increase in WR performed within the moderate-
intensity domain can be described by the kinetics of the phase II response. ‘Phase II’ is 
characterized as a mono-exponential curve (Hill, 1924; Mahler, 1985; Whipp et al., 2005), the 
nature of which can be described by Equation 1:  
2pOV& (t) = 2pOV& BSLN + A (1 – e-(t-TD)/τ)    Equation 1  
where 2pOV&
 (t) represents the 2pOV& at any given time (t); 2pOV& BSLN is the steady-state 
baseline value of 2pOV&  before an increase in WR (given as the average 2pOV&  value in the 80-20 
s period immediately prior to a transition); A is the amplitude of the increase in 2pOV&  above 
2pOV& BSLN; τ is the time constant and represents the time required to attain 63% of the steady-
state amplitude (with 86%, 95% and 98% of the SS achieved after 2τ, 3τ and 4τ, respectively); 
and TD represents the mathematically generated time delay through which the exponential model 
is predicted to intersect 2pOV& BSLN. The time constant (τ) for the phase II VO2 response (τ 2pOV&
) is believed to reflect the rate of adjustment of 2mOV& , and therefore acts as a proxy for the 
adjustment of mitochondrial oxidative phosphorylation).  
1.2 FACTORS LIMITING OXYGEN UPTAKE KINETICS 
The overall reaction describing oxidative phosphorylation can be summarized below in Equation 
2: 
NADH+ + H+ + 0.5 O2 + 3 ADP + 3 Pi  3 ATP + NAD+ + H2O  Equation 2 
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Should any one of the substrates required for oxidative ATP production (O2, NADH, ADP) be 
less than some “optimal” level, then this substrate could limit the rate of activation of oxidative 
phosphorylation, and thus slow 2pOV&  kinetics. However, a delay in the 2pOV&  response may not 
be due necessarily to lower concentration of a single substrate, but instead may be due to the 
interaction between the substrates. Hogan et al. (2005) observed that the increase in NADH was 
markedly greater when initiated from a point when exercise is initiated from a point of low 
muscle PO2 was low (Hogan et al., 2005). In exercising human muscle (Haseler et al., 1998), the 
rate of oxidative phosphorylation was well defended in the face of decreased O2 availability, 
which was mirrored by an increase in the concentration of [ADP]. The literature would suggest 
that instead of one determining factor the rate of 2pOV&  adjustment, there are a series of 
interacting aspects. Despite this, there exist two hypotheses concerning the limiting of the rate of 
adjustment of VO2p; (1) phase II 2pOV&  kinetics are limited by O2 delivery to the exercising 
muscle; (2) they are slowed by a sluggish activation of enzymes and provisions of substrates for 
oxidative phosphorylation  
1.3 REGULATION OF VO2p KINETICS BY O2 DELIVERY IN MODERATE 
EXERCISE 
There is a considerable amount of evidence to suggest that O2 delivery is the defining 
limitation to 2pOV&  kinetics.  In the literature, experiments have been performed that impair O2 
transport and delivery either via pharmacological means, modifying body position or by altering 
the inspired fraction of O2 (i.e., normoxia, hypoxia and hyperoxia) in order to study the impact 
on τ 2pOV& . Beta-adrenergic receptor blockade (which reduces cardiac output) and the supine 
posture (reducing perfusion pressure) have been shown to prolong τ VO2p (Hughson & 
Kowalchuk, 1991; MacDonald et al., 1998). Impairment of O2 delivery by acute bouts of 
hypoxia (FiO2 10-14%), and therefore the reducing of arterial PO2 (PaO2) have been employed to 
slow τ 2pOV&  during transitions within the moderate-intensity domain (Murphy et al., 1989; 
Hughson & Kowalchuk, 1995; Engelen et al., 1996). Furthermore, combining interventions that 
augment convective O2 delivery and metabolic substrate provision (i.e., the MOD-HVY-MOD 
protocol) with the addition of hypoxia (which presumably increases O2 delivery but impairs 
PaO2 through alterations in FiO2) have resulted in a lengthened τ 2pOV&  (Spencer et al., 2012b). 
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These results may suggest that O2 delivery is the major factor in the limitation of the rate of 
oxidative phosphorylation. However, when attempting to increase O2 availability, especially in 
the moderate-intensity domain, there seems to be no impact on τ 2pOV& . In the pump-perfused dog 
hindlimb model, Grassi and colleagues showed no speeding on 2pOV&  kinetics despite improving 
bulk, convective blood flow (Grassi et al., 1998) and peripheral, diffusive O2 delivery (Grassi et 
al., 1998). Work in the animal model (e.g., dog gastrocnemius muscle is highly oxidative and 
capillarized, and demonstrated rapid blood flow distribution), (Delp & Duan, 1996; Leek et al., 
2001) have yielded similar results as in the human model.  Hyperoxia (FiO2 >50%), has often 
failed to produce any speeding of 2pOV&  kinetics
 
(Hughson & Kowalchuk, 1995; Macdonald et 
al., 1997). However, inferences from the lack of speeding with improved FiO2 must be taken 
with caution. Hyperoxia also causes systemic vasoconstriction so that blood flow is adjusted 
(i.e., reduced) to maintain total O2 delivery (Macdonald et al., 1997). Expectations of an altered τ 
2pOV&  following changes in O2 delivery may be specific to the environment to which they are 
applied; in other words, initial τ 2pOV&  will likely play a role in determining whether or not and to 
what extent the rate of adjustment of VO2p is sped following any intervention which may 
improve O2 delivery to the working muscle. Poole et al. (2008) proposed there is a “point” 
beyond which 2pOV&  kinetics is O2 dependent such that the provision of O2 becomes limiting and 
thus τ 2pOV&  is lengthened  – though implications have been  made that this occurs only in elderly 
or diseased populations (Poole et al., 2007; Poole et al., 2008; Poole & Musch, 2010). In 
contrast, recent data have suggested that this O2 dependent point exist in young healthy adults as 
well, at least when the severity of a O2 delivery limitation is capable of impacting the  τ 2pOV&
(Murias et al., 2011). As such, interventions that affect provision of O2 to the active muscles (via 
convective and/or diffusive O2 delivery) are likely to alter the dynamic adjustment of oxidative 
phosphorylation even in young healthy populations – if the initial τ 2pOV&  is slow, and therefore 
can be altered by an improved O2 delivery.  
Near-infrared spectroscopy 
In order to effectively measure tissue oxygenation, the use of near-infrared spectroscopy (NIRS) 
has become a preferred method in the non-invasive observation of microvascular blood flow. 
  
6 
 
The NIRS measurements are based on the absorption of light wavelengths within the NIR range 
(~700-900nm) due to the differences in light absorption characteristics displayed by oxygenated 
hemoglobin [HbO2] and deoxygenated hemoglobin [HHb]. NIR light is projected from an 
emitting diode to a light-detecting optode (optical sensor device) after passing through tissue. 
Kallikoski et al. (2006) outlines that the penetration depth is approximately half the distance of 
the inter-optode spacing (Kalliokoski et al., 2006). [HHb] and [HbO2] are distinct based on their 
different light absorption characteristics, so by emitting light at several specific wavelengths in 
the NIR spectrum, the precise determination of the amount within the tissue under the area of 
interrogation is possible. The quantification of specific changes in [HbO2] and [HHb] via the 
NIRS method has been utilized to provide an index of O2 extraction during transitions from 
baseline to a new metabolic work rate. While the NIRS does not provide an estimate of a-
vO2diff, as circulation within the microvasculature cannot be concretely assessed: the [HHb] has 
been observed to match microvascular partial pressure (PO2mv) through the on-transient of 
exercise (Grassi et al., 2003). The NIRS method provides an insight into the local, microvascular 
O2 delivery to the working muscle and the rate of O2 utilization. 
1.4 REGULATION OF VO2P KINETICS BY SUBSTRATE PROVISION  
For oxidative phosphorylation to increase in the on-transient following a step-increase in 
WR, there must be an increase in provision of electrons and reducing equivalents (i.e., NADH; 
FADH2) to the mitochondrial electron transport chain (ETC). For the concentration of NADH to 
rise there must be an increase in either the breakdown of fat (via beta oxidation) or the 
production of pyruvate (stemming from glycolytic pathways). The production of pyruvate 
subsequently increases the tightly regulated pyruvate dehydrogenase (PDH) facilitated 
production of acetyl-CoA and flux through the tricarboxylic acid (TCA) cycle. Proponents of the 
hypothesis of a sluggish response in terms of metabolic activation that causes a slowing of 2pOV&
kinetics would suggest that if augmenting O2 delivery causes no perceptible changes in τ 2pOV& , 
then the limitation must lie within the metabolic pathways. PDH has been studied as a potential 
site of regulation for oxidative phosphorylation. The PDH complex exists in two forms: an 
inactive phosphorylated form and an active dephosphorylated form. Regulation of PDH is 
determined by enzymes PDH kinase (PDK) and PDH phosphatase (PDP) – increased activity of 
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PDK inhibits the activity of PDH (by phosphorylates the enzyme) while increased activity of 
PDP activates PDH (via dephosphorylation of the enzyme). The mitochondrial PDH complex 
catalyzes the oxidative decarboxylation of pyruvate, with production of Acetyl CoA, NADH and 
H+, and CO2,  and thus is responsible for regulating the entry of carbohydrate-derived substrate 
into the TCA , therefore, the provision of reducing equivalents to the ETC. Conflicting evidence 
lies in the literature in both human and canine models; by increasing the activation of PDH via a 
pharmacological intervention (dichloroacetate, DCA) (Timmons et al., 1996) , there was a 
marked reduction of the contribution of substrate-level phosphorylation during moderate  
exercise) (i.e., 65% 2pOV& max)  (Howlett et al., 1999). These findings would suggest that the 
reduction of substrate-level phosphorylation would stem from a more rapid activation of both 
oxidative phosphorylation and muscle O2 utilization. However, experiments in humans 
performed by Rossiter et al. (2003) in the heavy-intensity domain (Rossiter et al., 2003) and 
Koppo et al. (2004) in the moderate-intensity domain failed to demonstrate faster VO2p 
kinetics following prior PDH activation by DCA supplementation.  Also, Grassi et al. (2002) 
using an isolated dog gastrocnemius muscle preparation showed that despite an improved 
metabolic efficiency (i.e., ‘[PCr] sparing’), there were no effect on τ 2pOV&  (Grassi et al., 2002). 
The different findings in the literature may stem from differences in experimental models, 
techniques or inaccuracies in the modeling of τVO2p data, but also may stem from a limitation 
to reducing equivalent production elsewhere in the complex oxidative pathway (i.e., one of a 
number of enzymatic relationships found in the TCA). 
In order for oxidative phosphorylation to increase during the on-transient from one 
metabolic demand to another, ADP will increase in response to the breakdown of ATP; and thus, 
control of oxidative phosphorylation may reside within the creatine kinase (CK) reaction. As 
ATP is broken down at the level of the muscle, the instantaneous increase of the products of the 
hydrolysis (ADP, Pi) are moderated by the CK reaction. Chance & Williams (1955) proposed 
that within isolated mitochondrial preparations, increases in concentration of both free (un-
bound) adenosine diphosphate ([ADPfree]) and [Pi] would cause an increase in 2mOV&  (Chance et 
al., 1955). Interestingly, when CK was inhibited in a single isolated frog myocyte, there was an 
rapid fall in intracellular PO2 (which the authors believed was indicative of a rapid τ 2mOV& ) 
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(Kindig et al., 2005). The inference here is that there is a high correlation between the flux of CK 
and oxidative phosphorylation; the breakdown of PCr serves as a “buffer” against the increase in 
ADP and slows the further activation of oxidative phosphorylation. The authors suggested that 
the PCr pool may act as a potential ‘dampening system’ that protects oxidative phosphorylation 
from sudden swings in ATP requirement (Kindig et al., 2005). When the PCr system is no longer 
capable of buffering the rising ADPfree, ADPfree would likely be the driving force to increase 
oxidative phosphorylation. 
1.5 SLOWED VO2p KINETICS IN TRANSITIONS FROM RAISED METABOLIC 
RATES 
During exercise performed below Lθˆ , the steady-state 2pOV& -WR relationship is linear 
(Whipp & Wasserman, 1972). The kinetic adjustment during transitions between one WR and 
another gives a glimpse into possible mechanisms controlling O2 uptake. Hughson & Morrissey 
(1982) experimentally identified gas exchange kinetics (including 2pOV& ) when transitioning to a 
new WR from an elevated WR (relative to rest) (Hughson & Morrissey, 1982). The authors 
confirmed the observation that there exists a ‘non-linear’ relationship in the relationship between 
WR and 2pOV& during exercise transitions. The data from Hughson and Morrissey (1982) 
indicated not only a slower rate of adjustment of VO2p, but also an increase O2 cost per unit 
increase in WR (i.e., 2pOV&  gain; ∆ 2pOV& / ∆WR). Since the identification of this non-linear 
relationship, the control mechanism that governs such a relationship has received much attention. 
Using similar protocols these observations have been reproduced on a number of occasions, 
highlighting the relative “robustness” of these responses.  A modified “double-step” protocol 
was introduced by Brittain et al. (2001) which involved two step-transitions of equal magnitude 
(i.e., identical ∆WR) performed sequentially, with a ‘lower-step’ (LS) initiated from a light-
intensity WR (often using baseline leg cycling of 20W) to a higher WR midway between the 
baseline WR and a WR corresponding to ~90% Lθˆ (i.e., WR50) followed by an ‘upper-step’ 
(US) transition from WR50 to a WR corresponding to ~90% Lθˆ (WR90) (where ∆WRLS = 
∆WRUS) (Figure I) (Brittain et al., 2001).  In this study, and in others (Brittain et al., 2001; 
Spencer et al., 2012; Williams et al., 2013), despite the identical ∆WR transitions (reflecting 
possibly a similar increase in ATP turnover rate) maintained within the MOD-intensity domain, 
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slower 2pOV&  kinetics (i.e., a greater τ 2pOV& ) and a greater 2pOV&  gain (i.e., larger ∆ 2pOV& /∆WR) 
are reported consistently for the US compared to the LS.  The exact mechanism(s) responsible 
for this dynamic “non-linearity” currently are unknown.  Hughson and Morrisey (1982) proposed 
that “bulk” blood flow was slowed in the US as evidenced by slower heart rate kinetics (due to 
the relative sluggishness of sympathetic drive at the initiation of the US versus the rapid 
withdrawal of the parasympathetic system at the onset of the LS). This notion was supported by 
MacPhee et al. (2005) who reported slower heart rate (HR) and femoral (conduit) artery blood 
flow kinetics initiated from a high versus light baseline metabolic rate performed during 
alternate-leg knee-extension exercise however the relationship between blood flow and oxygen 
uptake remains unclear; in the same study, the rate of adjustment of muscle oxygen extraction (as 
measured by the near infared spectroscopy (NIRS)-derived [HHb] signal) was slowed in the US, 
suggesting that the delivery of O2 to the working muscle was sufficient and mirrored a slowed 
rate of 2pOV&  adjustment. (MacPhee et al., 2005). Brittian et al. (2001) proposed that the possible 
fiber-type recruitment strategy in the LS (primarily type I slow-twitch, highly oxidative fibers) 
versus those recruited in the US (“less efficient” fibers with slower 2pOV&  kinetics and greater 
2pOV&  gain). Bowen et al. (2011) attempted to dissociate the effects of muscle fibre recruitment 
from the effects of metabolic rate by having subjects perform a step-transition from a baseline of 
light-intensity exercise to a WR corresponding to 90% Lθˆ (WR90), allowing subjects a brief 
recovery last 30 s at the light-intensity WR which allowed 2pOV&  to recovery partially, and then 
transitioning back to WR90.   In this protocol 2pOV&  kinetics remained slow despite the step-
transition being initiated from a light-intensity WR (i.e., similar muscle fibre recruitment but 
elevated metabolic rate (high 2pOV& ) and muscle blood flow) (Bowen et al., 2011).  These data 
suggest that differences in the adjustment of 2pOV&  (and oxidative phosphorylation) within the 
“double-step” protocol may not due to muscle fibre type inefficiencies or to attenuated muscle 
blood flow and O2 delivery, but instead suggest that the metabolic status of the working muscle 
may play a role.  
During transitions from low to higher intensities of exercise the metabolic stability is not 
maintained but coincident with decreases in local muscle [PCr] and [ATP], increases in [Pi], 
[ADP
 free], [AMP free], [IMP free], and reductions in Gibbs free energy of ATP hydrolysis (∆GATP  
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= [ADPfree] • [Pi]/[ATP]). What is meant by the term metabolic stability is that the ratios of high 
energy phosphates are similar to those found at, in this case, baseline cycling. With respect to the 
“double-step” protocol, metabolic “stability” will be similar to baseline during the LS (initiated 
from a light-intensity baseline metabolic rate) than in the US (initiated from a higher-intensity 
baseline metabolic rate), with the fall in metabolic “stability” being exacerbated during the 
transitions when muscle energy production relies more heavily on substrate-level, rather than 
oxidative, phosphorylations The raised metabolic rate elicited by the LS potentially reduces the 
cellular energetic state within the working muscles (i.e., a reduction in PO2, [PCr] and increased 
[ADPfree] would lead inexorably to a diminished Gibb’s free energy (∆GATP) of ATP 
degradation) (Meyer, 1988) which has been shown both in silico (Kemp, 2008), in vivo (Barstow 
et al., 1994), and in vitro (Glancy et al., 2008). The implications of the diminished Gibb’s free 
energy would be that the energy released per hydrolysis of ATP would be diminished, perhaps 
leading to a greater ATP turnover for a given energetic output.  
The primary purpose of the study herein was to examine; (1) the rate of adjustment of 
VO2p , muscle dexoygenation and heart rate during transitions from low and elevated baseline 
metabolic rates within the MOD exercise domain; (2) the relationship between metabolites (i.e., 
[ADPfree], [ATP], [PCr],) measured via needle biopsy and τ 2pOV& .  
It was hypothesized (1) that 2pOV&  kinetics would be comparatively slower and that the 
2pOV&  gain would be greater during exercise transitions initiated from a higher metabolic rate; 
and (2) that muscle [PCr] would be lower, [ADPfree] and [Pi] would be higher, and the calculated 
∆GATP would be lower with exercise initiated from a higher metabolic rate; and (3) the τ 2pOV&  
would be inversely related to ∆GATP. Furthermore, bulk blood flow (as measured by HR) during 
exercise transitions initiated from an elevated metabolic rate will be slowed due to the 
lengthened rate of adjustment of oxidative phosphorylation, furthermore, the O2 extraction (as 
measured by the NIRS-derived [HHb] signal) will also be slowed.   
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Figure I: Schematic representation of the double-step, constant-load moderate intensity exercise 
test. The lower step (LS) involves a transition from light-intensity exercise (20 W) to a work rate 
representing 50% of the difference between 20 W and the estimated lactate threshold θL , (∆50); 
the upper step (US) involves a transition from ∆50 to 90% θL .  
  
  
12 
 
 
2 ADJUSTMENT TO PULMONARY VO2P, MUSCLE DEOXYGENATION AND 
METABOLISM DURING MODERATE INTENSITY TRANSITIONS INITIATED 
FROM LOW AND ELEVATED BASELINE METABOLIC RATES 
2.1 INTRODUCTION 
During an abrupt step-transition from rest to exercise, there is an immediate increase in 
energy turnover in the working skeletal muscle (Rossiter et al., 1999). In order to prevent a fall 
in intracellular [ATP], the increased ATP demand is met immediately by the provision of ATP 
via substrate-level phosphorylation (PCr degradation) and by an increase in flux through the 
glycolytic pathway resulting in increased [lactate] (La-). Coincident with this, the rate of 
mitochondrial oxidative phosphorylation increases in a time-dependent manner, becoming the 
principal method of sustained ATP production, thereby reducing the reliance on substrate-level 
phosphorylations. The rise in muscle O2 uptake ( 2mOV& ), and thus increase in oxidative 
phosphorylation, does not increase instantaneously with the immediate rise in ATP demand but 
instead, increases exponentially towards a new steady-state.  The rate of 2mOV&  increase at the 
muscle is reflected closely by the increase in pulmonary O2 uptake ( 2pOV& ) (Grassi et al., 1996; 
Koga et al., 2005), although the pulmonary expression of the 2mOV&  is shifted in time owing to 
the intervening muscle-to-lung blood volume and modulated by the ongoing increase in central 
and peripheral blood flow.  Despite this, the time course of  2mOV&  and the time course of the 
phase II 2pOV&  were shown to agree within ~ 10% (Barstow et al., 1994; Grassi et al., 1996; 
Koga et al., 2005). Should this abrupt increase in work rate (WR) lie within the moderate-
intensity domain (MOD), 2pOV&  will eventually (within ~2-3 min) realize and maintain a steady-
state (Whipp & Wasserman, 1972) 
During MOD exercise it has been demonstrated that the rate of adjustment of 2pOV&  
(determined by the 2pOV&  time constant (τ 2pOV& ) is lengthened, and the 2pOV&  gain (i.e., ∆ 2pOV&
/∆WR; reflecting the O2 cost of a given WR change) is greater when exercise is initiated from a 
higher compared to lower baseline metabolic rate in healthy young (Hughson & Morrissey, 
1982; Brittain et al., 2001; MacPhee et al., 2005; Bowen et al., 2011), elderly (Spencer et al., 
2011) and despite training (Williams et al., 2013). That the 2pOV&  kinetics response is dependent 
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on the baseline metabolic rate suggests a ‘dynamic nonlinearity’ within the moderate-intensity 
domain - i.e, a different “output” response ( 2pOV& ) despite the same “input” WR change.  
There have been a number of proposed mechanisms contributing to the slowed time 
course of adjustment of 2pOV&  during transitions from an elevated metabolic rate. Hughson and 
Morrissey (1982) proposed that the rate of convective and diffusive transport of O2 was 
responsible for the slowed 2pOV&  adjustment in transitions initiated from a raised WR. Slower 
adjustment of central blood flow was due to the relatively slow activation of the sympathetic 
system when compared to the rapid adjustment of heart rate (HR) seen due to withdrawal of 
parasympathetic neural activity. Consistent with this MacPhee et al. (2005) reported a slowed 
adjustment of conduit artery blood flow and slowed HR kinetics. The limitation of 2pOV&  via 
slowed bulk blood flow (O2 delivery) or from poor matching of O2 distribution to the working 
muscles within the microvasculature remains to be elucidated. Williams et al. (2013) suggested 
that following the abolishment of the ‘overshoot’ of the HHb-to- 2pOV&  ratio (as reflecting the 
abolishment of a greater reliance upon muscle O2 extraction to O2 consumption) following 
training made no impact on the slowed adjustment of 2pOV&  in transitions made from an elevated 
metabolic baseline.  
Alternatively, the slowed rate of adjustment of 2pOV&  may be related to muscle fibre 
recruitment and differences in kinetic and metabolic characteristics of the muscle fibres recruited 
during exercise transitions from a lower compared to higher WR and metabolic rate (Brittain et 
al., 2001). Muscle fibers recruited during lower compared to higher exercise intensities, even 
within the same exercise intensity domain, may differ in contractile characteristics, metabolic 
efficiency (ATP cost of force production and/or O2 cost of ATP production), mitochondrial 
content, capillarity and blood flow responses. Brittain et al. (2001) speculated that the motor unit 
pool from which fibers would be recruited in the low work rates would be more oxidative and 
‘efficient’ as compared to those recruited at a raised WR.  
Furthermore, Bowen et al. (2011) observed that when exercise transitions were initiated 
from a common light-intensity WR but with either a low or high 2pOV& , and thus different 
“baseline” metabolic rates, 2pOV&  kinetics were slower when exercise was initiated from the 
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higher baseline 2pOV& .  This suggests that energetic state of the recruited muscle may impact the 
adjustment of  2pOV&  (and 2mOV&  and mitochondrial oxidative phosphorylation) during an 
exercise transition - e.g., transitions from a higher baseline WR and/or metabolic rate would be 
expected to have lower muscle [PCr] and local [ATP]; greater [ADPfree] and [Pi], and lower 
Gibbs free energy of ATP hydrolysis (∆GATP) (Korzeniewski & Zoladz, 2006; Zoladz et al., 
2006).  A decrement in the cellular energetic status has been shown to be capable of slowing the 
rate of oxidative phosphorylation in ensuing transitions in healthy young (Barstow et al., 1994), 
isolated mitochondria in vitro (Glancy et al., 2008; Kemp, 2008).  Furthermore, while there have 
been studies that have examined transitions from the moderate-intensity domain into the heavy-
intensity domain (Jones et al., 2008; Dimenna et al., 2010b) the muscle metabolic response 
during a “double-step” protocol performed within the MOD exercise has not been examined.  
Therefore, the primary purpose of the study was to examine; (1) the rate of adjustment of 
VO2p and muscle deoxygenation during transitions from a low and elevated baseline metabolic 
rates performed within the MOD exercise domain; (2) the muscle metabolic response during 
these transitions using direct muscle sampling; and (3) the relationship between 2pOV&  kinetics 
and changes in specific muscle metabolites determining the muscle energetic state (i.e., 
[ADPfree], [ATP], [PCr], [Pi]). It was hypothesized 1) that 2pOV&  kinetics would be slower and 
that the 2pOV&  gain would be greater during exercise transitions initiated from a higher metabolic 
rate; and 2) that muscle [PCr] would be lower, [ADPfree] and [Pi] would be higher, and the 
calculated ∆GATP would be lower with exercise initiated from a higher metabolic rate; and 3) the 
τ 2pOV&  would be inversely related to ∆GATP. 
2.2 METHODS 
Participants. Young, healthy men (n = 10; 25 ± 2 yr; mean ± SD) volunteered and gave written 
informed consent to participate in this study. All procedures were approved by The University of 
Western Ontario’s Research Ethics Board for Health Sciences Research Involving Human 
Subjects. Participants were recreationally active and non-smokers, and had no known 
cardiovascular, respiratory, metabolic or musculoskeletal disease, nor were they taking 
medications that might affect the cardiorespiratory and hemodynamic responses to exercise. 
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Participants were instructed not to consume food or caffeine two hours prior to visits to the 
laboratory for data collection.  
Exercise protocol. At the start of the study, participants reported to the laboratory to perform a 
ramp incremental exercise test (20-25 W/min) to the limit of tolerance on a cycle ergometer 
(model: H-300-R Lode; Lode B.V., Groningen, Holland) for determination of peak 2pOV&  (
peak 2pOV& ) and estimated lactate threshold ( Lθˆ ); the ramp portion of the protocol was initiated 
after 4 min baseline cycling at 20 W. Participants were asked to maintain a cycling cadence 
between 60-70 rpm. The Lθˆ  was estimated by visual inspection using standard gas exchange and 
ventilatory measures as described previously (Beaver et al., 1986) and using the following 
criteria:  the 2pOV&  at which 2pCOV&  CO2 output ( 2pCOV& ) began to increase out of proportion in 
relation to 2pOV& , with a systematic rise in minute ventilation ( EV& )-to- 2pOV&  ratio and end-tidal 
PO2, whereas the EV& -to- 2pCOV&  ratio and end-tidal PCO2 remained stable (Beaver et al., 1986). 
From the results of the ramp incremental test, a moderate-intensity WR (WR90) was selected to 
elicit a 2pOV&  equivalent to ~ 90% of the 2pOV&  at Lθˆ . Subjects returned to the laboratory on five 
separate occasions and performed a “double-step” exercise protocol which consisted of: 6 min 
baseline cycling at 20 W, followed by a lower step-transition (LS) from 20 W to a WR (WR50) 
midway between 20 W and the WR90 (∆WRLS), and then followed immediately by an upper 
step-transition (US) from WR50 to WR90 (∆WRUS); both step transition were performed 
consecutively and the change in WR was identical for both transitions (i.e., ∆WRLS = ∆WRUS). 
Transitions lasted 6 min to establish a well-defined 2pOV&  state-state
 
( 2ssOV& ). Participants 
maintained a cadence of ~ 70 rpm during these tests, which they monitored on a screen in front 
of them.  
Muscle sampling. During an additional visit to the laboratory, muscle biopsies were obtained 
from the vastus lateralis muscle using the needle biopsy technique (Bergstrom, 1975) as the 
subjects performed ‘double-step’ exercise transitions, consistent with the above protocol. Before 
exercise, five biopsy sites (three on the left leg and two on the right leg) were prepared under 
local anesthesia (2% lidocaine without epinephrine) by making small incisions through the skin 
to the deep fascia. The subject then moved to the cycle ergometer and began baseline cycling at 
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20 W. A muscle biopsy sample was taken after 4 min baseline cycling and again at 15 s and 6 
min during each of the step-transitions to LS. Two minutes of cycling were added following the 
needle biopsy at the steady-state in LS prior to the biopsy taken during the transition from LS to 
US to allow for the re-establishment of steady-state in the LS. Muscle biopsy samples were 
frozen immediately in liquid N2 (<10 s from the cessation of exercise), removed from the needle 
while frozen, and stored in liquid N2 until later analysis.  
2pOV&  measurement. Gas exchange measurements were similar to those previously described 
(Babcock et al., 1994). Briefly, inspired and expired volumes were measured using a low dead 
space (90 mL) bidirectional turbine (Alpha Technologies VMM 110) which was calibrated 
before each test using a syringe of known volume. Inspired and expired gases were continuously 
sampled (50 Hz) at the mouth and analyzed for concentrations of O2, CO2, and N2 by mass 
spectrometry (Innovision, AMIS 2000, Lindvedvej, Denmark) after calibration with precision-
analyzed gas mixtures. Changes in gas concentrations were aligned with gas volumes by 
measuring the time delay for a square-wave bolus of gas passing the turbine to the resulting 
changes in fractional gas concentrations as measured by the mass spectrometer. Data were 
transferred to a computer, which aligned concentrations with volume information to build a 
profile of each breath. Breath-by-breath alveolar gas exchange was calculated by using 
algorithms of Beaver et al. (1981). 
 
Near-infrared spectroscopy. Local muscle deoxygenation ([HHb]) of the quadriceps vastus 
lateralis muscle was monitored continuously with a frequency-domain multi-distance near-
infrared spectroscopy (NIRS) system (Oxiplex TS, Model 95205, ISS, Champaign, IL, USA) as 
described elsewhere (Spencer et al., 2012a). The probe was placed on the belly of the muscle, 
midway between the lateral epicondyle and greater trochanter of the femur; it was secured in 
place with an elastic strap tightened to prevent movement and covered with an optically-dense, 
black vinyl sheet, thus minimizing the intrusion of extraneous light and loss of NIR light. An 
elastic bandage was applied to further minimize intrusion of extraneous light and probe 
movement. NIRS measurements were collected continuously for the entire duration of each trial. 
Briefly, the system was comprised of a single channel consisting of eight laser diodes operating 
at two wavelengths (λ = 690 and 828 nm, four at each wavelength) which were pulsed in a rapid 
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succession (110 MHz) and a photomultiplier tube. The lightweight plastic NIRS probe 
(connected to laser diodes and photomultiplier tube by optical fibers) consisted of two parallel 
rows of light emitter fibers and one detector fiber bundle; the source-detector separations for this 
probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. 
The NIRS was calibrated at the beginning of each testing session following an instrument 
warm-up period of at least 20 min (as recommended by the manufacturer). Calculation of [HHb] 
reflected continuous measurements of a reduced scattering coefficient (µs’) made throughout 
each testing session (i.e., constant scattering value not assumed). Data were stored online at an 
output frequency of 25 Hz, but were reduced to 1 s bins for all subsequent analyses within the 
present study.  
Heart-rate measurement. HR was monitored continuously by electrocardiogram (three-lead 
arrangement) using PowerLab (ML132/ML880; ADInstruments, Colorado Springs, CO) and was 
calculated (using a 5 s rolling average) based upon the R-R interval. Data were recorded using 
LabChart v6.1 (ADInstruments, Colorado Springs, CO) on a separate computer. 
Modelling of the 2pOV& , HR and NIRS deoxygenation responses. Breath-by-breath 2pOV&  data 
were edited by removing data that lay outside 4 standard deviations of the local mean (Lamarra 
et al., 1987) The remaining data were interpolated to 1 s intervals, and time-aligned so that time 
zero represented the initiation of the step-increase in WR.  
The ensemble-averaged, second-by-second 2pOV&  and HR responses were further time-
averaged into 5 s bins. The on-transient responses for 2pOV&  and HR were modeled using the 
following equation:  
Y(t) = YBSLN + A (1 – e-(t-TD)/τ)     Equation 1  
where Y(t) represents the 2pOV&  or HR at any given time (t); YBSLN is the steady-state baseline 
value of Y before an increase in WR (given as the average Y value in the 80-20 s period 
immediately prior to a transition); A is the amplitude of the increase in Y above YBSLN; τ is the 
time constant and represents the time required to attain 63% of the steady-state amplitude; and 
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TD represents the mathematically generated time delay through which the exponential model is 
predicted to intersect YBSLN. Data were modeled from Phase I 2pOV&  in the fitting of Phase II 
while still allowing TD to vary freely (in order to optimize accuracy of parameter estimates). 
2pOV&  data were modeled to 4 min (240 s) of the step-transition; this ensured that each subject 
had attained a 2pOV&  steady-state, yet did not bias the model fit during the on-transient (Bell et 
al., 2001). HR data were modeled from exercise onset to the end of the 6 min exercise transition 
with TD constrained to ≥ -10 s and baseline fixed as described above (i.e., 60 s average during 
the 80-20 s period prior to a transition). The model parameters were estimated by least-squares 
nonlinear regression (Origin, OriginLab Corp., Northampton, MA, USA) in which the best fit 
was defined by minimization of the residual sum of squares and minimal variation of residuals 
around the Y-axis (Y = 0). The 95% confidence interval (CI95) for the estimated time constant 
was determined after preliminary fit of the data with YBSLN, A, and TD constrained to the best-fit 
values and the τ allowed to vary.   
The mean response time (MRT) (Linnarsson, 1974) of 2pOV&  described the overall time 
course of 2pOV&  during the exercise transition and was estimated using the function described in 
Eq. 1, but with inclusion of all VO2p data from the onset of exercise, and the TD constrained to 
0 s. This approach allowed for an estimate of the O2 deficit (Rossiter et al., 1999) for each WR 
transition. The O2 deficit provides information on non-oxidative energy transfer and was 
calculated as: 
O2 deficit (1) = MRT (s) * ∆ 2pOV& ss (L/min) * min/60s  Equation 2 
The functional gain of the fundamental VO2p response was calculated as ∆ 2pOV& ss/∆WR 
(ml·min−1·W−1), where 2pOV& ss is steady-state increase in O2 uptake above baseline. 
The NIRS-derived [HHb] profiles were time-aligned and ensemble-averaged into 5 s bins 
to yield a single response time for each subject. The time-course of adjustment for the [HHb] 
profile has been previously described as consisting of a time delay at the onset of exercise, with a 
subsequent “exponential-like” increase in the signal with time of exercise (DeLorey et al., 2003). 
The time delay for the [HHb] response (TD[HHb]) was determined visually using the second-by-
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second data and corresponded to the time between the step-increase in WR and the time where 
the [HHb] signal began a systematic increase from its nadir value. Determination of the 
TD[HHb] was made on individual response profiles, averaged for the five trials and reported as 
the WR-specific response for each subject. The ensemble-averaged [HHb]responses were 
modeled from TD[HHb] to 90 s of the transition, with a monoexponential function of the form in 
Eq. 1 to determine the time course of muscle [HHb] (τ[HHb]). A systematic decline in [HHb] did 
not occur prior to 90 s of the transition in any subjects Baseline [HHb] ([HHb]BSLN) values were 
fixed as the mean value in the 80-20 s period leading up to a transition, as described above with 
2pOV&  and HR. Whereas the τ[HHb] describes the time course for the increase in [HHb], the 
effective time constant, or mean response time, of [HHb] (τ’[HHb] = TD [HHb] + τ[HHb]) 
described the overall time course of the [HHb] from the onset of each step transition. 
Muscle analysis. Small pieces of frozen wet muscle (55-60 mg) were removed from each biopsy 
under liquid N2 for the determination of PDH activity as described elsewhere (Putman et al., 
1993). An aliquot of each muscle enzyme homogenate was then extracted with 0.5 mol.L-1 
perchloric acid (HCIO4), containing 1 mmol.L-1 EDTA, and neutralized with 2.2 mol.L-1 
KHCO3. The supernatant from the extracts was used for the enzymatic spectrophotometric 
determination of total creatine. Enzyme measurements were normalized to the highest total 
creatine content measured from all biopsies from each subject. A portion of muscle from each 
biopsy was freeze dried, dissected free of visible blood and connective tissue, and powdered for 
metabolic and glycogen analyses. An aliquot of freeze-dried muscle (10-12 mg) was extracted 
with 0.5 mol.L-1 perchloric acid, containing 1 mmol.L-1 EDTA, and neutralized with 2.2 mol.L-1 
KHCO3. The supernatant was used to determine creatine, [PCr], ATP, and lactate levels, with 
enzymatic spectrophotometric assays (Bergmeyer, 1974). Muscle glycogen content was 
determined from 2 aliquots of freeze-dried muscle from all biopsies, as described elsewhere 
(Bergmeyer, 1974). Muscle metabolites were corrected for total creatine, as described above. 
Calculations. Muscle contents of free [ADP] ([ADPfree]) and AMP were calculated by assuming 
equilibrium of the creatine kinase and adenylate kinase reactions, respectively (Dudley et al., 
1987). The [ADPfree] was calculated by using the measured [ATP], [Cr], [PCr], estimated [H+] 
concentration, and the creatine kinase equilibrium constant of 1.66 x 106; [H+] concentration was 
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calculated from the measured pyruvate and lactate contents as described by Sahlin et al. (1976) 
(Sahlin et al., 1976). Free inorganic phosphate (Pi) in exercise was calculated by assuming an 
estimated free phosphate content at rest of 10.8 mmol/kg dry wt (Dudley et al., 1987) and adding 
this value to the difference in [PCr] content relative to the baseline value (Harris et al., 1974). 
The Gibbs free energy change for ATP hydrolysis (∆GATP) was calculated as described 
previously (Meyer, 1988). 
Statistics. Values are presented as mean ± SD.  Parameter estimates for 2pOV& , NIRS-derived 
[HHb] and HR, and muscle metabolite data were analyzed using repeated-measures ANOVA 
with time as within-subject factor using SPSS version 20.0 (SPSS, Chicago, IL).  Statistical 
significance was accepted at p < 0.05. 
2.3 RESULTS 
Absolute and relative workloads of US and LS. The ∆WR from the baseline to the LS was 62 ± 
16 (LS WR = 82 ± 16 W) was 63 ± 0.1% of the Lθˆ , and 35 ± 0.1 % of the peak 2pOV& . The ∆WR 
from the LS to US was 62 ± 16 (LS WR =143 ± 43 W) was 89 ± 0.1% of the Lθˆ , and 50 ± 0.1 % 
of the peak 2pOV& . A summary of subject characteristics are presented in Table 1. 
2pOV&  kinetics. Figure 1 displays the VO2p response profile for all subjects (Fig. 1A) and for a 
representative subject (Fig. 1B) during exercise transitions initiated from a low and higher 
metabolic rate and WR, including model line-of-best-fit and residuals. A summary of parameter 
estimates for the on-transient 2pOV&  response for the LS and US aspects of the protocol are 
presented in Table 2. The τ 2pOV&  was greater (p<0.05) in the US (34 ± 12 s) compared to the LS 
(20 ± 8 s). Despite the identical increase in WR in LS (62 ± 16 W) and US (62 ± 16 W), the 
2pOV& gain (∆ 2pOV& /∆WR) was greater (p<0.05) in the US (10.37 ± 1.49) versus that of the LS 
(8.51 ± 1.41).  The calculated O2 deficit was greater in the US (0.48 ± 0.25 L) than in the LS 
(0.30 ± 0.14 L). 
NIRS-Derived [HHb] Kinetics and Muscle Oxygenation Parameters. The ensemble-averaged 
[HHb] group response during the LS and US transitions (Fig. 2A) and the [HHb] response for a 
representative subject (Fig. 2B) are presented in Figure 2, including model line-of-best-fit and 
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residuals. The group mean profiles of total hemoglobin content ([THC]; Fig. 3A), O2 saturation 
(%O2sat; Fig. 3B), oxygenated hemoglobin ([HbO2]; Fig. 3C), and deoxygenated hemoglobin 
([HHb]; Fig. 3D) are displayed in Figure 3. A summary of parameter estimates for the on-
transient [HHb] response for LS and US are presented in Table 3. The time delay (TD) before the 
increase in muscle deoxygenation, although not different statistically (p = 0.06), tended to be 
greater in LS (10 ± 3 s) and US (7 ± 4).  After the TD, the rate of adjustment of [HHb] (τ[HHb]) 
was greater (p<0.05) in US (16 ± 5 s) than in LS (11 ± 5 s); the overall rate of adjustment of 
muscle deoxygenation from the start of the exercise transitions (i.e., effective time constant or 
mean response time (τ’[HHb] = τ[HHb] + TD) was not different in US (22 ± 7 s)  and LS (22 ± 7 
s).  The [HHb]bsl and [HHb]ss were greater (p<0.05) in US than in LS, while the [HHb]amp was 
lower (p<0.05) in US (Table 3).  
Heart rate response. A summary of parameter estimates for the on-transient HR response for LS 
and US are presented in Table 4. The rate of adjustment of heart rate (τ HR) was slowed (p<0.05)  
during the transition in the US (29 ± 9 s) compared to the LS (17 ± 9 s). The HRbsl, HRamp and 
HRss were elevated significantly (p<0.05) in the US versus the LS (Table 4).   
Muscle metabolite content. Changes in the measured and calculated muscle metabolites are 
presented in Tables 5 and 6.  Muscle ATP content ([ATP]) remained at the BSL20W level (21.2 ± 
1.0 mmol/kg dw) during the LS and US exercise transitions (Table 5).  Muscle [PCr] tended to 
be lower (p = 0.06) at LS15s (74 ± 3 mmol/kg dw) compared to BSL20W (79 ± 2 mmol/kg dw), 
and was further reduced (p<0.05) at LS360s (67 ± 3 mmol/kg dw) and US360s (63 ± 3 mmol/kg 
dw) (Table 5).
 
 The relative decrease in [PCr] for an identical WR change (∆[PCr]/∆WR) was 
not different between US and LS.  Muscle [Pi] tended to increase (p=0.06) from BSL20W (10.8 
mmol/kg dw) to LS15s (15.5 ± 2 mmol/kg dw), and was higher (p<0.05) from BSL20W and LS15s 
at LS360s (22.8 ± 3 mmol/kg dw) and US360s (26.8 ± 3 mmol/kg dw) (Table 5).  There was an 
elevation (p<0.05) in muscle [ADPfree] from the BSL20W (85 ± 4 µmol/kg dw) at LS15s (101.26 ± 
6 µmol/kg dw) and remained elevated (p<0.05) from BSL20W throughout the transitions.  There 
was also a greater (p<0.05) muscle [ADPfree]  at US360s (131 ± 13 µmol/kg dw) than at LS360s 
(123 ± 10 µmol/kg dw) (Table 5). The increase in ∆[ADPfree] during LS and US were not 
different.  The calculated ∆GATP at the LS360s and US360s were similar and both were lower than 
  
22 
 
the ∆GATP at BSL20W (Table 5).   There was a strong positive correlation (Pearson’s r correlation 
coefficient = 0.62) between τ 2pOV&  and ∆GATP  during transitions from both low and elevated 
steady-states.  The group, ensemble average response of [ADPfree] following transitions from 
lower and elevated metabolic baselines are illustrated in Figure 4. The steady-state and modeled 
transition 2pOV&  as a function of [ADPf] and [PCr] (Figure 5, 6 respectively) during moderate 
intensity double-step exercise transitions are shown. 
Muscle [lactate-] content was elevated (p<0.05) above BSL20W throughout the entire 
protocol (Table 6); the muscle [lactate-] at US360s was greater (p<0.05) than at LS360s. Muscle 
[H+] remained at BSL20w throughout the MOD exercise transitions. 
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Table 1. Subject characteristics 
Parameter  
Age, yrs 23 ± 3 
Mass, kg 86 ± 10 
Height, cm 183 ± 6 
peak 2pOV& , L/min 4.31 ± 0.47 
peak 2pOV& , mL/kg/min 50 ± 4 
 
2.4 ± 0.27  
Values are means ± SD;
 
VO2 peak, peak O2 uptake; , estimated lactate threshold. 
Lθˆ
Lθˆ
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Table 2. 
 
kinetics parameters for LS and US moderate-intensity exercise transitions 
Parameter  
 LS US 
bsl L/min 1.00 ± 0.12 1.54 ± 0.23* 
ss, L/min 1.54 ± 0.23 2.20 ± 0.43* 
2pOV&  amp, L/min 0.52 ± 0.15 0.63 ± 0.20 
TD, s 15 ± 4 10 ± 7 
τ , s 20 ± 8 34 ± 12* 
C95, s 7 ± 2 7 ± 3 
∆ ss/∆WR, 
mL/min-1/W-1 
8.51 ± 1.41 10.37 ± 1.49* 
O2 deficit 0.30 ± 0.14
 
0.48 ± 0.25* 
ss, %VO2max 35.3 ± 4.4 49.9 ± 8.8* 
WR, W 82 ± 16 143 ± 32* 
Values are means ± SD; bsl, baseline ; ss, steady-state ; amp, amplitude of 
 response; TD, time delay; τ ,  time constant for  response; C95, 95% confidence 
interval of τ ; ∆ ss/∆WR, functional gain. *Different from LS (P < 0.05). 
 
 
 
 
 
 
 
2pOV&
2pOV&
2pOV&
2pOV&
2pOV&
2pOV&
2pOV& 2pOV& 2pOV& 2pOV&
2pOV& 2pOV& 2pOV&
2pOV& 2pOV&
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Table 3. [HHb] kinetics parameters for LS and US moderate-intensity exercise transitions 
Parameter  
 LS US 
[HHb]bsl,  a.u. 22.8 ± 5.6 26.6 ± 7.9*  
[HHb]ss, a.u. 25.6 ± 9.6 29.7 ± 10.3* 
[HHb]amp, a.u. 4.3 ±3.5 3.5 ± 2.6* 
TD, s
 
 10 ± 3 7 ± 4+  
τ[HHb], s 11 ± 5 16 ± 5*  
τ'[HHb], s 22 ± 7 22 ± 7 
  
 
Values are means ± SD; [HHb]bsl, baseline; [HHb]ss, fitted steady-state; TD, calculated time 
delay; τ[HHb],  time constant for [HHb] response; τ', effective time constant (τ[HHb] + TD); 
*Different from LS (P < 0.05);  + (P = 0.06) 
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Table 4. 
 
Parameter estimates for HR kinetics for LS and US moderate-intensity exercise 
transitions 
Parameter  
 LS US 
   
HR bsl (beats/min) 89.5 ± 11 102 ± 10*  
HR ss(beats/min) 103 ± 11 123 ± 13*  
HR amp 15 ± 4 21 ± 7*  
τHR, s 17 ± 9 29 ± 9* 
C95, s 7 ± 4 6 ± 3 
Values are means ± SD;  HR bsl, baseline HR; HR ss, steady-state HR; amp, amplitude of HR 
response; TD, time delay; τHR,  time constant for HR response; C95, 95% confidence interval of 
τHR. *Different from LS (P < 0.05).  
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Table 5. Muscle content of [PCr], [ATP], [ADPfree], and [Pi] for LS and US moderate-intensity 
exercise transitions 
 
Parameter   
  LS  US 
 BSL20W LS15s LS360s US15s US360s 
[ATP] 21.19 22.04 21.58 23.73 21.66 
 ±0.98 ±1.27 ±0.64 ±0.64 ±1.40 
[PCr] 79.01 74.27 67.05*† 69.97* 63.40*† 
 ±1.51 ±2.80 ±2.74 ±3.20 ±3.38 
[Pi] 10.8 15.54 22.76*† 20.29* 26.78*† 
 ±0 ±2.44 ±3.13 ±3.29 ±3.44 
[ADPfree] 85.06 101.26* 123.32* 124.92* 131.30*† 
 ±4.30 ±5.79 ±10.42 ±14.51 ±13.04 
∆GATP -56.40 -55.31 -53.79*† -54.86 -53.26*† 
 ±0.39 ±1.36 ±1.49 ±2.33 ±1.59 
Values are means ± SD. Muscle biopsies samples at steady-state baseline at 20W (BSL20W), at 15 
s during the exercise transition into the lower (LS15s) and upper (US15s) steps, and at steady-state 
after 360 s exercise in the lower (LS360s) and upper (US360s) steps. Muscle [Pi] was assumed to be 
10.8 mmol/kg dw at rest (Dudley et al., 1987), with the increase during exercise equivalent to the 
fall in muscle [PCr].  Muscle [ADPfree] calculated according to (Dudley et al., 1987)and Gibbs 
free energy (∆GATP) calculated according to (Meyer, 1988). Units are mmol/kg dry wt except 
free [ADP] ([ADPfree]) which is in µmol/kg dry wt and ∆GATP , which are in kJ/mol. P <0.05, 
significant difference vs. BSL20W (*), vs. LS15s (†),vs. LS360s (‡), vs. US15s (§), vs. US360s  
Table 6. Muscle contents of lactate- and c[H+]  for LS and US moderate-intensity exercise 
transitions 
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Parameter   
  LS US 
 BSL20W LS15s LS360s US15s US360s 
[Lactate-] 4.11 5.69* 8.20* 8.06* 14.32*†‡§ 
 ±0.42 ±0.78 ±1.70 ±2.15 ±3.20 
c[H+] 108.85 110.42 113.04 113.66 118.91 
 ±1.30 ±2.45 ±5.66 ±6.82 ±10.40 
 
Values are means ± SD. Muscle biopsies samples at steady-state baseline at 20W (BSL20W), at 15 
s during the exercise transition into the lower (LS15s) and upper (US15s) steps, and at steady-state 
after 360 s exercise in the lower (LS360s) and upper (US360s) steps. Muscle content values are 
expressed as mmol/kg dry wt except for calculated H+ concentration (c[H+]), which is expressed 
as 10-9 mol/L. P <0.05, significant difference vs. BSL20W (*), vs. LS15s (†),vs. LS360s (‡), vs. 
US15s (§), vs. US360s 
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Figure 1A. Ensemble-averaged, group mean breath-by-breath 2pOV&  responses to moderate intensity double-step transitions as a 
function of time. Figure 1B. 2pOV&  response to exercise transitions in the LS and US for a representative subject showing model line-
of-best-fit and residuals.  Dashed vertical lines represent the time of onset of the LS and US. 
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Figure 2A. Ensemble-averaged, group mean NIRS-derived [HHb] response to moderate intensity double-step transitions as a function 
of time. Figure 2B. NIRS-derived [HHb] response to exercise transitions in the LS and US for a representative subject showing model 
line-of-best-fit and residuals.  Dashed vertical lines represent the time of onset of the LS and US. 
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Figure 3. Ensemble-averaged NIRS-derived profiles for total hemoglobin content ([THC]; 3A), 
%O2 saturation ([%O2sat];3), oxyhemoglobin content ([HbO2]; 3C), and deoxyhemoglobin 
content ([HHb]; 3D ), during LS and US transitions  Dashed vertical lines represent the time of 
onset of the LS and US. 
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Figure 4. Intramuscular [ADPfree] (µmol/kg dry wt) at steady state baseline (BSL;20W), and at 
15s and 360s during the transitions into LS and US. Values are mean ± SD. Vertical dashed lined 
indicate the time corresponding to an instantaneous increase in work rate for the lower (LS; time 
= 0s) and upper (US; time = 360s) step-transitions.  
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Figure 5. Relationship between [ADPfree] (µmol/kg dry wt)  and estimated muscle oxygen 
uptake (L/min) during lower and upper step transitions in work rate. Values are mean ± SD 
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Figure 6. Relationship between [PCr] (mmol/kg dry wt)  and estimated muscle oxygen uptake 
(L/min) during lower and upper step transitions in work rate. Values are mean ± SD 
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2.4 DISCUSSION 
This study investigated the adjustments to pulmonary O2 uptake ( 2pOV& ), NIRS-derived 
muscle deoxygenation ([HHb]), and muscle metabolism during moderate-intensity step-
transitions in work rate initiated for a low and elevated metabolic rate. In agreement with 
previous reports (MacPhee et al., 2005; Bowen et al., 2011; Spencer et al., 2011; Williams et al., 
2013) when exercise was initiated from a high (US) compared to low (LS) baseline metabolic 
rate: (1) the rate of adjustment of 2pOV&  was slower (i.e., the τ 2pOV&  was longer) and the 2pOV&  
gain (∆VO2p /∆WR) was greater in US; (2) the delay before a rise in muscle deoxygenation 
(TD [HHb]) was shorter (p=0.06) and the adjustment of [HHb] was slower (longer τ[HHb]) in 
US, but the overall rate of adjustment of muscle deoxygenation (τ’[HHb]) was not different 
despite slower 2pOV&  kinetics in US; and (3) HR kinetics were slower in US.  Novel findings 
related to the muscle metabolic response during the moderate-intensity “double-step” exercise 
transitions were that:  (4) the increase in muscle [ADPfree] and [Pi], and decrease in muscle [PCr] 
that occurred during exercise transitions into LS, tended to be greater than seen during transitions 
into the US, despite identical increases in WR and slower 2pOV&  kinetics (and thus, presumably, a 
slower adjustment of muscle oxidative phosphorylation); and (5) the Gibbs free energy for ATP 
hydrolysis (∆GATP) was lower in LS and US compared to BSL20W, but was not different between 
LS and US.   
To our knowledge, this is the first study to examine the kinetics of 2pOV& and muscle 
deoxygenation in combination with intramuscular high energy phosphate metabolism during 
exercise transitions constrained within the moderate-intensity exercise domain but initiated from 
a lower and higher baseline metabolic rates.  The slower adjustment of 2pOV&  and greater 
increase in 2pOV&  for a given ∆WR (∆ 2pOV& /∆WR) when exercise was initiated from the higher 
compared to lower baseline metabolic rate may provide information on limitation and regulation 
of 2pOV& , and thus on activation of muscle mitochondrial respiration. 
Collectively, these data suggest that; (1) activation and adjustment of mitochondrial 
oxidative phosphorylation is slower, and the O2 cost per ∆WR (and per ∆[ATP requirement]) 
 36 
 
was greater when exercise is executed from a higher baseline metabolic rate; (2) the greater 
steady-state increase in 2pOV&  (and mitochondrial oxidative phosphorylation) in US (0.69 L/min) 
compared to LS (0.54 L/min) and slower 2pOV&  kinetics in US (τ 2pOV& , 34 s vs. LS, 20 s) cannot 
be explained simply by the absolute increase in [ADPfree] (US, 8.0 vs. LS, 38.3 µmol/kg dw), or 
[Pi] (US, 4.0 vs LS, 12.0 mmol/kg dw), or by the absolute decrease in [PCr] (US, 3.7 vs. LS, 
12.0 mmol/kg dw), or ∆GATP (US, -0.53 vs. LS, -2.61 kJ/mol), which were all the same or lower 
in US than in LS; and (3) a slowed adjustment of O2 delivery to muscle (based on slower HR 
kinetics (perhaps reflecting a slower adjustment of cardiac output and central bulk blood flow; 
and similar overall adjustment of muscle deoxygenation (reflecting muscle fractional O2 
extraction and thus the local muscle microvascular blood flow-to-O2 utilization ratio). 
Three hypotheses have been advanced to explain the relatively slow adjustment of 2pOV&  
(and 2mOV& , and thus mitochondrial oxidative phosphorylation) compared to the instantaneous 
increase in muscle ATP turnover that are seen during transitions to exercise.  These can be 
summarized as:  (1) an O2 delivery limitation where convective and diffusive O2 delivery to 
muscle and the mitochondrial cytochrome oxidase is not sufficient (Tschakovsky & Hughson, 
1999); and (2) a “sluggish” activation of rate limiting enzymes and provision of oxidative 
substrate (other than O2) (i.e., reducing equivalents (NADH; FADH2, ADP, Pi) to the 
mitochondrial TCA cycle and ETC (Grassi, 2000, 2001; Jones et al., 2011; Rossiter, 2011); (3) 
that 2pOV&  is slowed when initiated from a high compared to low baseline metabolic rate and WR 
is observed consistently, regardless of whether the exercise transitions are confined within the 
moderate-intensity domain (Hughson & Morrissey, 1982; di Prampero et al., 1989; Brittain et 
al., 2001; MacPhee et al., 2005; Spencer et al., 2011; Williams et al., 2013) , or whether the 
transitions are performed in both the moderate- and heavy-intensity domains (i.e., intensities 
below and above Lθˆ ) (Wilkerson & Jones, 2007; DiMenna et al., 2010a). Studies using the 
double-step protocol have primarily focused upon mechanisms by which the US is slowed 
compared to the LS; however, to our knowledge there have been no other studies that have 
identified the concentrations of intramuscular metabolites during transitions from low and 
elevated baselines within the moderate domain. The resting [PCr]/[ATP] ratio was ~4 and the 
resting [Pi]/[ATP] ratio was ~0.5, similar values to those reported in the literature (Kemp et al., 
2007; Jones et al., 2008). Furthermore, when observing transitions from rest to moderate 
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intensity exercise, Jones et al. (2008) observed a ~15% degradation of intramuscular [PCr] 
(measured by 31P-MRS), similar to data herein which indicated a ~20% degradation of [PCr] 
from rest at the US. Importantly, Jones et al. (2008) also observed that when transitions were 
made from elevated metabolic rates versus rest, [PCr] fell to a lesser extent- similar to the data 
herein.   
Hughson and Morrissey (1982) proposed that the slowed 2pOV&  kinetics observed in the 
transition to the US was due to an O2 delivery limitation imposed by slow HR kinetics. MacPhee 
et al. (2005) observed a slowed rate of adjustment of blood flow both centrally (estimated via 
heart rate) and peripherally (measured via femoral artery blood flow) on the knee-extension 
ergometer. The observations in the present study are in agreement with previous data pertaining 
to slow HR kinetics during transitions from elevated metabolic rates (Hughson & Morrissey, 
1982; MacPhee et al., 2005). These data may indicate O2 delivery could be responsible for the 
lengthened τ 2pOV&  seen in transitions from the LS to the US. Also, in the present study the time 
delay before the increase in muscle deoxygenation (reflecting muscle mvQ& -to- 2mOV& ) was shorter 
in the US, and the overall rate of adjustment of muscle deoxygenation was not different between 
US and LS, despite the slowed 2pOV&  kinetics, suggesting that the adjustment of microvascular 
blood flow and O2 delivery may be slower in the US than in the LS.  This suggests that an 
immediate increase in O2 availability consequent to an increase in WR, via a muscle pump 
action, vasodilation or a combination of the two (Tschakovsky & Hughson, 1999) is more 
effective during transitions from a low compared to a higher metabolic and WR. However, in the 
present study, the steady-state end-exercise [HHb]amp/ 2pOV& amp  was lower in the US than in the 
LS indicating reduced reliance on O2 extraction as steady-state blood flow is achieved.  These 
findings differ from those reported by MacPhee et al. (2005), who observed an increased in 
∆[HHb]/∆ 2pOV&  in the US in young men performing knee-extension exercise, and those reported 
by Spencer et al. (2011) who observed no difference in the steady-state end exercise [HHb]amp/
2pOV& amp  between the two step-transitions in elderly men performing leg cycling. The unchanged 
mean-response time (MRT) of the [HHb] signal during transitions from the elevated metabolic 
demand versus that of the LS must be closely examined; despite similar MRT, the TD[HHb] in 
the US was faster than that in the LS, yet this is matched with a lengthened τ[HHb]. This would 
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suggest that there are two distinguishable responses of microvascular O2 extraction. In the early 
part of the response, there is a shortened time period (TD [HHb]) in the US during which O2 
extraction (as a mirrored profile of microvascular PO2 (PO2mv)) is sufficient given the transition 
from an elevated metabolic rate perhaps due to transiently sufficient blood flow; that is to say 
that O2 delivery (blood flow) is sufficient for less time in the transition from LS to US versus 
from baseline to LS. In the late response, the slowed τ[HHb] in the US would likely reflect a 
defense of the O2 driving pressure and attenuation of the drop in microvascular PO2 (PO2mv) at 
the onset of a transition from an elevated metabolic rate. It would seem that in the US, blood 
flow is initially sufficient for a lesser period of time (versus LS) when the VO2p kinetic response 
is being established. This is in line with slow HR kinetics during the transition from an elevated 
metabolic baseline. Therefore, it would appear that during transitions from elevated metabolic 
rates within the moderate intensity domain, τ 2pOV& may be limited by an O2 delivery issue.  
Brittain et al. (2001) speculated that muscle fibers active in the LS were recruited 
sequentially from a pool of fibers which were more oxidative and efficient (i.e., with lower 2pOV&
gain) as compared to muscle fibres recruited in the US, which had different metabolic 
characteristics even if they classified within the same fibre type (based on myosin heavy chain 
isoforms). Lower-order fibers have lower recruitment thresholds and are activated when 
contractile intensity is low, while activity at greater intensities (often above Lθˆ ) require the 
recruitment of higher-order fibers, which have observed to yield slowed 2pOV&  kinetics and lower 
efficiency in both human (Barstow et al., 1996; Pringle et al., 2003) and animal (Crow & 
Kushmerick, 1982) models. The increase in lactate observed in this study may be indicative of a 
reliance on less efficient, glycolytic fibers (type II) in  the US as compared to the lower step. 
Another possible hypothesis proposed to explain the slowed adjustment of VO2p in 
transitions from an elevated metabolic baseline within the moderate intensity domain is that the 
metabolic rate itself (and thus, the energetic state of the active muscle) influences the rate of 
adjustment (Bowen et al., 2011). We observed an increase in [ADPfree] and [Pi] during the 
transition from the baseline to the LS (without a change in muscle [ATP]), which contributed a 
fall in calculated ∆GATP . As a consequence, the energetic state of the exercising muscle at the 
onset of the transition from this elevated baseline (i.e transition to the US), was less favourable 
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than at the start of the lower (LS) exercise transition. The free energy released per ATP 
hydrolysis would likely be diminished due to the accumulation of metabolites (Zoladz et al., 
2006). Therefore, for a given WR, the required ATP turnover would be greater – this may help to 
explain the increased in ∆ 2pOV&  /∆WR observed in the US. In the present study, there was a 
moderately strong relationship between the rate of adjustment of oxidative phosphorylation (i.e., 
2pOV& ) and the energetic status of the muscle (measured via ∆GATP calculation). It has been 
shown that 2pOV&  kinetics and ∆GATP are linked, in that a fall in ∆GATP  has been observed to be 
related to an lengthened τ 2pOV& (Barstow et al., 1994; Kemp, 2008). A possible consequence of 
lower baseline ∆GATP is that a greater ATP turnover (and greater 2mOV& ) would be needed to 
support a given change in WR. This notion stems from the work of Glancy et al. (2008), who 
suggested that the energy delivery to the actin-myosin crossbridges found within the active 
muscle is equivalent to the product of ATP production and ∆GATP. We observed that the 2pOV&  
gain was greater in the US concomitant with a ‘less favorable’ energetic state. Therefore, a less 
negative ∆GATP during US might be responsible for the higher 2pOV&  gain (∆ 2pOV& /∆WR) found 
in the present study and in others (MacPhee et al., 2005; Bowen et al., 2011; Spencer et al., 
2011; Williams et al., 2013).  If correct, this would suggest that the change in ATP requirement 
in the US was greater than in LS, despite ∆WR being the same.  We have no evidence to support 
an alternate explanation that the increase in ATP turnover rate is similar for the same ∆WR in LS 
and US, and it is a fall in mitochondrial ATP-to-O2 coupling efficiency (P/O) that is reduced. 
Furthermore, it is interesting that the ∆GATP is significantly lower even during the first transition 
(i.e., LS15s) as compared to the baseline, and is again lower at the LS360s as compared to the LS15s 
- providing insight that there may be a dynamic or transient decrease in ∆GATP during exercise 
transitions in the moderate-intensity domain.  
While comparisons with studies using different experimental models and interventions 
must be made with caution, models of respiratory control may provide an explanation for the 
slowed rate of adjustment of 2pOV&  in the US. Accumulation of [Pi] and [ADPfree] and their links 
with oxidative phosphorylation have received much attention. The notion of a dynamically 
increasing ATP turnover for a given workload is not consistent with the model of linear 
capacitance proposed by Meyer (Meyer, 1988) as the model would predict that the steady-state 
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2pOV&  – [PCr] relationship is linear over any given work rate. While this model has been 
contested (Kemp, 2008; Wust et al., 2011) the observations in the present study (with limited 
muscle sampling) would suggest that the steady-state 2pOV& - [PCr] relationship is linear across 
both the LS and the US transitions within the moderate intensity domain (Figure 6). In terms of 
[ADPfree] accumulation, an early model (based, in vitro, on isolated mitochondrial preparations) 
proposed that 2mOV&  was determined by [ADPfree] and [Pi] in a manner related to hyperbolic, 
first-order Michaelis-Menten enzyme kinetics (Chance et al., 1955), although this relatively 
simple control is not as apparent in more intact muscle cells in vivo (Saks et al., 1998). However, 
studies have observed that the in vivo ADP- 2mOV&  relationship may be too steep to be described 
by first-order dynamics as there is a ‘high sensitivity’ of 2mOV&  to small changes in ADP at low 
[ADP] expected at rest and during the early part of the transition to a higher intensity (Jeneson et 
al., 1996; Jeneson et al., 2009).   During steady-state, the relationship between ∆GATP and 
oxidative phosphorylation would suggest that larger increases in [ADPfree] and [Pi] are required 
for a greater rise in oxidative phosphorylation at higher metabolic rates (Jeneson et al., 1995). In 
the present study, muscle [ADPfree] already was elevated after 15 s of the LS transition, but did 
not increase statistically for the remainder of the LS and US transitions, despite further 
adjustments in VO2p.  The [ADPfree] presented in the present study are consistent with values 
reported by Howlett and colleagues with exercise transitions from rest to either 35%, 65% or 
90% 2pOV& max (Howlett et al., 1998).  The relationship between muscle [ADPfree] and 2pOV&  is 
presented for the present study in Figure 5.  Unlike the models and data showing large increases 
in 2mOV&  with relatively small changes in [ADPfree] (see; Dudley et al., 1987; Katz et al., 1989; 
Jeneson et al., 1996; Kemp, 2008; Wust et al., 2011), the curvilinear relationship shown for the 
present study suggests that sensitivity of whole body 2pOV&  to muscle [ADPfree] is lower during 
the transition in LS than during the transition to US.  However, the time and intensity dependent 
increase in “apparent ADPfree sensitivity” (i.e., for very small increases of [ADPfree], there is a 
large increase in VO2m) for whole body 2pOV&  more likely reflects the overall up-regulation of 
oxidative phosphorylation consequent to provision of other substrates to the mitochondria, and to 
a complex up-regulation, via covalent and allosteric regulation, of TCA cycle and ETC rate-
limiting enzymes which is beyond the scope of the present study. Activation the mitochondrial 
PDH complex by pharmacological interventions (dichloroacetate) or ‘priming’ exercise (Gurd et 
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al., 2009) has been shown to reduce the O2 deficit and reliance on substrate-level 
phosphorylation as shown by an attenuation of muscle PCr and glycogen breakdown, and lower 
accumulating content of [Pi], [ADPfree], [lactate-], and [H+], metabolic responses consistent with 
a greater activation of  mitochondrial oxidative phosphorylation.  
Limitations 
One limitation in this study is related to the protocol involving needle biopsies. To reduce 
the discomfort of the subject, we opted to take three biopsies from one leg, and two from the 
other. The variability of not only tissue within one leg, but between legs themselves, may serve 
as a confounding factor. Furthermore, while we had hoped to capture the alterations in the 
metabolites following transitions to a new steady state, the timeline may be too quick (i.e., 15s) 
to observe a large increase. The timeline was designed in order to capture the increase of PDH –
as it has been observed that after 30s, PDH is already at steady state (Gurd et al., 2009). Another 
limitation is related to the use of the NIRS, as the area of muscle under the optodes (i.e., the area 
of “interrogation”) represents only a small region of active muscles, and may not necessarily 
quantify the contribution of all the working fibers, nor all the working muscles, in the 
examination of the rate of adjustment of [HHb]. Finally, we must make the assumption that VO2p 
is accurately reflecting what is occurring at the level of the muscle ( 2mOV& ) (Barstow et al., 
1990). 
2.5 CONCLUSION 
In summary, this study presented novel insight into the control of oxygen uptake during 
transitions from lower and elevated metabolic rates in the moderate intensity exercise domain. 
Slowed VO2p kinetics and a greater VO2p gain were observed in transitions from an elevated 
metabolic rate, coincident with slow HR kinetics (reflecting slow central (bulk) blood flow 
adjustments) and similar overall muscle deoxygenation kinetics (implying inadequate 
microvascular blood flow adjustments) during the same transitions. Additionally, despite slower 
2pOV&  kinetics in the US compared to the LS, the fall in muscle [PCr] and calculated ∆GATP, and 
rise in [Pi] and [ADPfree] during the US was less than the changes observed during the LS 
transition.  While the lower ∆GATP  observed during the LS steady state offers a possible 
explanation for the slower 2pOV&  kinetics and greater 2pOV&  gain observed in the US, the 
 42 
 
magnitude of the changes in the US of high-energy phosphates were (unexpectedly) small and 
did not seem consistent with metabolic changes expected based on a slow adjustment of 2pOV&  
(and muscle oxidative phosphorylation).  
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